Fundraising FoxMoonLake
2 known investors
Find your way into MoonLake
Sign up to see every warm intro you have to MoonLake
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MoonLake team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MoonLake develops treatments for serious inflammatory diseases, focusing on its investigational antibody Sonelokimab targeting the IL-17A and IL-17F pathways. Its clinical programs address skin and joint conditions including hidradenitis suppurativa and psoriatic arthritis.
Founders & leadership
Investors · 2
Frequently asked questions
- What does MoonLake do?
- MoonLake develops treatments for serious inflammatory diseases, focusing on its investigational antibody Sonelokimab targeting the IL-17A and IL-17F pathways. Its clinical programs address skin and joint conditions including hidradenitis suppurativa and psoriatic arthritis.
- Who founded MoonLake?
- MoonLake was founded by Jorge Santos da Silva.
- Who are MoonLake's investors?
- MoonLake's investors include Hercules Capital, Inc., Threshold Ventures.